Evercore ISI Downgrades Crinetics (CRNX) to In Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St headed for weekly gains as earnings season nears
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts CRNX Hot Sheet
Price: $84.95 --0%
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Evercore ISI analyst Gavin Clark-Gartner downgraded Crinetics (NASDAQ: CRNX) from Outperform to In Line with a price target of $85.00 (from $88.00).
For an analyst ratings summary and ratings history on Crinetics click here. For more ratings news on Crinetics click here.
Shares of Crinetics closed at $83.53 yesterday.
You May Also Be Interested In
- Teva Pharma (TEVA) PT Raised to $52 at Oppenheimer
- Owens Corning (OC) PT Lowered to $143 at DA Davidson
- Helen of Troy (HELE) PT Raised to $29 at UBS on Q2 Beat
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
